High Quality Evidence of Guangzhou Lupus Nephritis Cohort (HOPE Cohort)
HOPE
1 other identifier
observational
5,000
1 country
1
Brief Summary
The goal of this observational study is to learn about the long-term renal and patient's survival of lupus nephritis (LN) patients in China. The main question it aims to answer is: Does the renal and patient's survival improved in the long term period? Participants who had renal biopsy proven lupus nephritis in one hospital will be followed up.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jan 1996
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 1996
CompletedFirst Submitted
Initial submission to the registry
November 1, 2024
CompletedFirst Posted
Study publicly available on registry
November 12, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2050
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 31, 2050
November 12, 2024
November 1, 2024
55 years
November 1, 2024
November 8, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Rate of patients with end stage renal disease
End stage renal disease
From data of enrollment until the data of first documented end stage renal disease, assessed up to 50 years
Secondary Outcomes (1)
Rate of patient's mortality
From data of enrollment until the data of death, assessed up to 50 years
Interventions
No Intervention: Observational Cohort
Eligibility Criteria
Patients who had biopsy proven lupus nephritis in The First Affiliated Hospital of Sun Yat-sen University
You may qualify if:
- Patients who had biopsy proven lupus nephritis in The First Affiliated Hospital of Sun Yat-sen University
You may not qualify if:
- less than 14 years old
- refused to give written consent
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
The First Affiliated Hospital of Sun Yat-sen University
Guangzhou, Guangdong, 510080, China
Biospecimen
Renal tissue from renal biopsy, urine, serum, DNA, PBMC, stool.
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Wei Chen, MD PHD
First Affiliated Hospital, Sun Yat-Sen University
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- OTHER
- Target Duration
- 30 Years
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Director of Department of Nephrology
Study Record Dates
First Submitted
November 1, 2024
First Posted
November 12, 2024
Study Start
January 1, 1996
Primary Completion (Estimated)
December 31, 2050
Study Completion (Estimated)
December 31, 2050
Last Updated
November 12, 2024
Record last verified: 2024-11